Literature DB >> 28876292

Cerebral Syphilitic Gumma Can Arise Within Months of Reinfection: A Case of Histologically Proven Treponema pallidum Strain Type 14b/f Infection With Human Immunodeficiency Virus Positivity.

Yusuke Koizumi, Takeya Watabe, Yasunori Ota, Shu-Ichi Nakayama, Nobuhiro Asai, Mao Hagihara, Yuka Yamagishi, Hiroyuki Suematsu, Toyonori Tsuzuki, Masakazu Takayasu, Makoto Ohnishi, Hiroshige Mikamo.   

Abstract

A 44-year-old man with human immunodeficiency virus positivity developed cerebral gumma 6 months after appropriate therapy for secondary syphilis. It was surgically resected and histologically, Treponema pallidum (14b/f, a relatively rare strain type) was proven. A complete set of modern techniques was performed to depict rare complication of this classic disease.

Entities:  

Mesh:

Year:  2018        PMID: 28876292     DOI: 10.1097/OLQ.0000000000000701

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

Review 1.  Syphilitic Gummata in the Central Nervous System: A Narrative Review and Case Report about a Noteworthy Clinical Manifestation.

Authors:  Lennart Barthel; Susann Hetze; Sarah Teuber-Hanselmann; Valérie Chapot; Ulrich Sure
Journal:  Microorganisms       Date:  2021-04-23

2.  Cerebral Syphilitic Gumma in Immunocompetent Man, Japan.

Authors:  Tatsuya Kodama; Hidenori Sato; Morichika Osa; Yuji Fujikura; Akihiko Kawana
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

3.  Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male.

Authors:  Khanh Pham; Lee Gottesdiener; Matthew S Simon; Alex Trzebucki; Grace A Maldarelli; Babacar Cisse; Joshua Lieberman; Elliot DeHaan; David Pisapia
Journal:  Open Forum Infect Dis       Date:  2021-08-31       Impact factor: 3.835

Review 4.  Possible effects of Treponema pallidum infection on human vascular endothelial cells.

Authors:  Bibo Xie; Tie Zhao; Sisi Zhao; Jie Zhou; Feijun Zhao
Journal:  J Clin Lab Anal       Date:  2022-03-10       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.